RT @sentimentstock: $NWBO study … P3 #DCVax-L for #GBM #glioblastoma… future platform treatment for all solid tumours. :)

RT @rfrosencrans: This entire concept is unreal. They fed samples of a patient’s own brain tumor to purified dendritic cells from the same…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @hoodicris: $NWBO

NEWS IS STARTING TO TAKE HOLD ... $NWBO #DCVax #ParadigmShift #Moonshot #murcidencel @POTUS @FoxNews @nbcwashington @abcnews @CBSWashDC

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

Now the world can know what @NorthwestBio has known all along. $nwbo #cancercure @POTUS @drsanjaygupta @Merck #dcvax #murcidencel

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @jhod: @JAMAOnc @HenryMuney Amazing news for glioblastoma patients! 🙌 Now get this approved and to them as fast as possible, please! @P…

@JAMAOnc @HenryMuney Amazing news for glioblastoma patients! 🙌 Now get this approved and to them as fast as possible, please! @POTUS… Moonshot, please!

#mercidencel @NorthwestBio #glioblastoma #allsolidtumors

@joealertz one to keep an eye on. Promising results of a Clin III trial for GBM therapy. Potential medical breakthrough and finally getting media attention. #NWBO https://t.co/ZDagt2hT3U

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

$NWBO. JAMA: “This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who receive

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

$NWBO

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

الدراسة نشرت في مجلة JAMA Oncology

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

$NWBO OTC gem will be properly valued only after uplisting to Nasdaq; buyout or partnership can do the trick too

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

$NWBO study … P3 #DCVax-L for #GBM #glioblastoma… future platform treatment for all solid tumours. :)

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

#DCVAX $NWBO

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…

$NWBO

This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatmen

Ph III clinical trial: Major data showing that DC vaccines prolong survival of Glioblastoma patients!! Long awaited results that address a cancer that failed to respond to anti-PD1 immunotherapy! It's time to take DC vaccines seriously for GBM treatment!!

RT @drew1016727129: 🎶She's a bad mama JAMA🎶🎶 https://t.co/TuvAPyyXiQ https://t.co/JmSVyJ0UFs…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

$NWBO #DCVAX

https://t.co/inn1QfNXAN

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @GaladonGaming: CONGRATS to $NWBO, its shareholders, and more importantly cancer patients around the world! https://t.co/OOhkBH26gI #N…

Good morning America! @amy_harmon @ldtimmerman @TheRealDanSfera @MarkSchoenebaum @matthewherper @reutersBenHir @Dereklowe @pharmalot @megtirrell @AndyBiotech @JohnCendpts Now this: https://t.co/Ji6ltP29NJ

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @MDCearns: Hot off the press 4 hours ago… Trial evidence of survival benefit particularly for recurrent #glioblastoma from a dendritic…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @rago_carlo: $NWBO JAMA article out today describing their P3 clinical trial wins in newly diagnosed AND recurrent GBM!! https://t.co/9…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @AlMusella: https://t.co/sowFiBVVhA The DCVAX peer reviewed journal article is now available online! #DCVAX #SNO2022 #GBM

RT @drew1016727129: 🎶She's a bad mama JAMA🎶🎶 https://t.co/TuvAPyyXiQ https://t.co/JmSVyJ0UFs…

RT @biggercapital: https://t.co/rre6ASD01D $NWBO JAMA > @statnews #GBM

RT @MDCearns: Hot off the press 4 hours ago… Trial evidence of survival benefit particularly for recurrent #glioblastoma from a dendritic…

RT @crypto_biotech: $NWBO huge. If you have some loose change- here is your chance. Diluted market cap on OTC- but the r/r is powerfully al…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @PaulJErdman: This is the real deal now! $NWBO #NWBO 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

@ACInvestorBlog Good Afternoon Antonio, take a look at $NWBO. Just released groundbreaking results of their brain cancer Ph III clinical trial in JAMA. This is a platform for not only brain cancer but for all cancers; a new approach to fighting cancer. htt

@Doc_Hieu $NWBO #DCVax-L #JAMA https://t.co/pfRDJT4azX https://t.co/xUgn2GF1MZ

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

🎶She's a bad mama JAMA🎶🎶 https://t.co/TuvAPyyXiQ https://t.co/JmSVyJ0UFs Congratulations LL! Paving the road leading to future combo treatments that could eventually be applicable to ALL SOLID TUMORS with

RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…

@RomyNiChleirigh the more technical bit!

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

Great news for GBM patients! Earlier data already confirmed association of CD4/8+ infiltration with response. So this also might have some implications for cellular Tx. #GD2 #CAR https://t.co/BKJn5tFB8c

RT @ichiipsy: 対照患者の選び方については少し気になるけれど、有効な結果が得られたというのは興味深い。 Association of DCVax-L With Extension of Survival Among Patients With Glioblasto…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @biggercapital: https://t.co/rre6ASD01D $NWBO JAMA > @statnews #GBM

$NWBO huge. If you have some loose change- here is your chance. Diluted market cap on OTC- but the r/r is powerfully alluring. @biggercapital is the biggest Tute. He finds diamonds in the rough. Here is the chance on the cheap. Multi-bag potentially. Highe

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

This is the real deal now! $NWBO #NWBO 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

#NWBO $NWBO

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

対照患者の選び方については少し気になるけれど、有効な結果が得られたというのは興味深い。 Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/dUyj534KW8 @JAMAOnc part of @JAMANetworkより

#NWBO #DCVax #murcidencel @WTOP Right here in Bethesda, MD "[DCVax]... ranks [as] one of the most commercially and medically important drugs ever developed by the biopharma industry." (MicroCap Daily) $nwbo https://t.co/CPmtXODAz4 https://t.co/Ev4FuwSk1o

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

FUN FACT: $nwbo 10 bagger < 3 months

Al fin cambios en el horizonte!!! https://t.co/VvJ23w18f3

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma. A Phase 3 Prospective Externally Controlled Cohort Trial https://t.co/Hq2vtWQBTG

עוד צעד חשוב בתחום חיסונים, או יותר נכון טיפולים, מותאמים אישית. ניסוי פאזה 3 מוצלח לחיסון נגד גליובלסטומה. לא מדובר בתרופת פלא אבל ההתקדמות המדעית ברורה. העתיד נמצא כאן. https://t.co/BSi5gbeo0g

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% still alive at 5 yrs. Few SAEs. Immunotherapy and cellular therapy taking another step forward with autologous dendritic cell vaccines!

RT @ATLnsider: Thank you Dr. Musella for@posting the link to the #DCVax-L #murcidencel journal article in JAMA. Great news for $NWBO!!: htt…

RT @jonathan5tymes: Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally…

Promising results for GBM treatment in a phase 3 trial! https://t.co/uobvSUHBb3

@bradloncar 🤣🤣🤣Still missing the biggest news in cancer $NWBO https://t.co/ShdYPdNrR1 😎https://t.co/Ji7W5ACPjJ. https://t.co/7adR6b9IFa

RT @crypto_biotech: $NWBO Journal if phase 3 published today. Stock is running hard. Could hit $2 today. Legit JAMA! Authored by the brain…